Trends in cancer,
Год журнала:
2022,
Номер
9(3), С. 223 - 236
Опубликована: Ноя. 29, 2022
Glioblastoma
(GBM)
remains
the
most
lethal
primary
brain
cancer
largely
due
to
recurrence
of
treatment-resistant
disease.
Current
therapies
are
ultimately
ineffective
as
GBM
tumour
cells
adapt
their
identity
escape
treatment.
Recent
advances
in
single-cell
epigenetics
and
transcriptomics
highlight
heterogeneous
cell
populations
tumours
originating
from
unique
cancerous
genetic
aberrations.
However,
they
also
suggest
that
conserve
molecular
properties
parent
neuronal
cells,
with
permissive
epigenetic
profiles
enabling
them
morph
along
a
finite
number
reprogramming
routes
evade
Here,
we
review
known
tumourigenic,
neurodevelopmental
brain-injury
boundaries
plasticity,
propose
effective
treatment
requires
addition
therapeutics
restrain
plasticity.
Cancer Cell,
Год журнала:
2022,
Номер
40(6), С. 639 - 655.e13
Опубликована: Июнь 1, 2022
Glioblastomas
are
malignant
tumors
of
the
central
nervous
system
hallmarked
by
subclonal
diversity
and
dynamic
adaptation
amid
developmental
hierarchies.
The
source
reorganization
within
spatial
context
these
remains
elusive.
Here,
we
characterized
glioblastomas
spatially
resolved
transcriptomics,
metabolomics,
proteomics.
By
deciphering
regionally
shared
transcriptional
programs
across
patients,
infer
that
glioblastoma
is
organized
segregation
lineage
states
adapts
to
inflammatory
and/or
metabolic
stimuli,
reminiscent
reactive
transformation
in
mature
astrocytes.
Integration
imaging
mass
cytometry
uncovered
locoregional
tumor-host
interdependence,
resulting
exclusive
adaptive
programs.
Inferring
copy-number
alterations
emphasizes
a
cohesive
organization
subclones
associated
with
programs,
confirming
environmental
stress
gives
rise
selection
pressure.
A
model
stem
cells
implanted
into
human
rodent
neocortical
tissue
mimicking
various
environments
confirmed
originate
from
environments.
Nature Reviews Drug Discovery,
Год журнала:
2023,
Номер
22(6), С. 496 - 520
Опубликована: Апрель 28, 2023
Single-cell
technologies,
particularly
single-cell
RNA
sequencing
(scRNA-seq)
methods,
together
with
associated
computational
tools
and
the
growing
availability
of
public
data
resources,
are
transforming
drug
discovery
development.
New
opportunities
emerging
in
target
identification
owing
to
improved
disease
understanding
through
cell
subtyping,
highly
multiplexed
functional
genomics
screens
incorporating
scRNA-seq
enhancing
credentialling
prioritization.
ScRNA-seq
is
also
aiding
selection
relevant
preclinical
models
providing
new
insights
into
mechanisms
action.
In
clinical
development,
can
inform
decision-making
via
biomarker
for
patient
stratification
more
precise
monitoring
response
progression.
Here,
we
illustrate
how
methods
being
applied
key
steps
discuss
ongoing
challenges
their
implementation
pharmaceutical
industry.
There
have
been
significant
recent
advances
development
remarkable
Ferran
colleagues
primarily
pipeline,
from
decision-making.
Ongoing
potential
future
directions
discussed.
Nature Immunology,
Год журнала:
2022,
Номер
23(6), С. 971 - 984
Опубликована: Май 27, 2022
Abstract
Glioblastoma
(GBM)
is
an
incurable
primary
malignant
brain
cancer
hallmarked
with
a
substantial
protumorigenic
immune
component.
Knowledge
of
the
GBM
microenvironment
during
tumor
evolution
and
standard
care
treatments
limited.
Using
single-cell
transcriptomics
flow
cytometry,
we
unveiled
large-scale
comprehensive
longitudinal
changes
in
cell
composition
throughout
progression
epidermal
growth
factor
receptor-driven
genetic
mouse
model.
We
identified
subsets
proinflammatory
microglia
developing
GBMs
anti-inflammatory
macrophages
myeloid-derived
suppressors
cells
end-stage
tumors,
that
parallels
breakdown
blood–brain
barrier
extensive
receptor
+
cells.
A
similar
relationship
was
found
between
patient
biopsies
low-grade
glioma
GBM.
Temozolomide
decreased
accumulation
suppressor
cells,
whereas
concomitant
temozolomide
irradiation
increased
intratumoral
GranzymeB
CD8
T
but
also
CD4
regulatory
These
results
provide
unbiased
cellular
landscape
its
evolutionary
progression.
Neuro-Oncology,
Год журнала:
2021,
Номер
24(5), С. 669 - 682
Опубликована: Ноя. 23, 2021
Phenotypic
plasticity
has
emerged
as
a
major
contributor
to
intra-tumoral
heterogeneity
and
treatment
resistance
in
cancer.
Increasing
evidence
shows
that
glioblastoma
(GBM)
cells
display
prominent
intrinsic
reversibly
adapt
dynamic
microenvironmental
conditions.
Limited
genetic
evolution
at
recurrence
further
suggests
mechanisms
also
largely
operate
the
phenotypic
level.
Here
we
review
recent
literature
underpinning
role
of
GBM
creating
gradients
heterogeneous
including
those
carry
cancer
stem
cell
(CSC)
properties.
A
historical
perspective
from
hierarchical
nonhierarchical
concept
CSCs
towards
appreciation
is
provided.
Cellular
states
interact
dynamically
with
each
other
surrounding
brain
shape
flexible
tumor
ecosystem,
which
enables
swift
adaptation
external
pressure
treatment.
We
present
key
components
regulating
equilibrium
states,
genetic,
epigenetic,
factors.
discuss
context
resistance,
where
variable
balance
between
preexisting
resistant
adaptive
persisters
leads
reversible
upon
Innovative
efforts
targeting
regulators
state
transitions
treatment-resistant
are
needed
restrict
capacities
GBM.
Cancer Discovery,
Год журнала:
2021,
Номер
12(2), С. 468 - 483
Опубликована: Ноя. 24, 2021
Oncogenic
extrachromosomal
DNA
elements
(ecDNA)
play
an
important
role
in
tumor
evolution,
but
our
understanding
of
ecDNA
biology
is
limited.
We
determined
the
distribution
single-cell
copy
number
across
patient
tissues
and
cell
line
models
observed
how
cell-to-cell
frequency
varies
greatly.
The
exceptional
intratumoral
heterogeneity
suggested
ecDNA-specific
replication
propagation
mechanisms.
To
evaluate
transfer
genetic
material
from
parental
to
offspring
cells
during
mitosis,
we
established
CRISPR-based
ecTag
method.
leverages
breakpoint
sequences
tag
with
fluorescent
markers
living
cells.
Applying
mitosis
revealed
disjointed
inheritance
patterns,
enabling
rapid
accumulation
individual
After
ecDNAs
clustered
into
hubs,
hubs
colocalized
RNA
polymerase
II,
promoting
transcription
cargo
oncogenes.
Our
observations
provide
direct
evidence
for
uneven
segregation
shed
new
light
on
mechanisms
through
which
contribute
oncogenesis.
SIGNIFICANCE:
are
vehicles
oncogene
amplification.
circular
nature
affords
unique
properties,
such
as
mobility
behavior.
uncovered
fundamental
properties
by
tracking
live
cells,
highlighting
random
that
drive
gene
transcription.See
related
commentary
Henssen,
p.
293.This
article
highlighted
In
This
Issue
feature,
275.
Genomic
alteration
can
reshape
tumor
microenvironment
to
drive
malignancy.
However,
how
PTEN
deficiency
influences
microenvironment-mediated
cell-cell
interactions
in
glioblastoma
(GBM)
remains
unclear.
Here,
we
show
that
induces
a
symbiotic
glioma-M2
macrophage
interaction
support
glioma
progression.
Mechanistically,
-deficient
GBM
cells
secrete
high
levels
of
galectin-9
(Gal-9)
via
the
AKT-GSK3β-IRF1
pathway.
The
secreted
Gal-9
drives
M2
polarization
by
activating
its
receptor
Tim-3
and
downstream
pathways
macrophages.
These
macrophages,
turn,
VEGFA
stimulate
angiogenesis
growth.
Furthermore,
enhanced
Gal-9/Tim-3
expression
predicts
poor
outcome
patients.
In
models,
blockade
signaling
inhibits
suppresses
Moreover,
α-lactose
attenuates
down-regulating
macrophage-derived
VEGFA,
providing
novel
antivascularization
strategy.
Therefore,
our
study
suggests
is
effective
impair
progression
inhibiting
polarization,
specifically
for
-null
GBM.